London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel (Jeremy Kahn/Fortune)
Jeremy Kahn / Fortune:
London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel — A trio of former Palantir executives who helped spearhead that company's Life Sciences practice have founded a startup called Perceptic …
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)